Therapeutic targeting of ACLY in T-ALL in vivo
V. da Silva-Diz, A. Singh, M. Aleksandrova, O. Kim, C. Thai, O. Lancho, P. R. Nunes, H. Affronti, X. Su, K. Wellen, D. Herranz
This study identifies ACLY as an overexpressed therapeutic target in T-ALL, showing its antileukemic effects and reciprocal relationship with MYC.
bioRxiv · Mar 27, 2023Cancer Biology